Prelude Capital Management’s M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share MBSC.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding MBSC.WS
AFM
BFM
SCM
PC
SC
MI
AC
LA
Prelude Capital Management's MBSC.WS Position: Q2 2023 in Review
Prelude Capital Management sold out of M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (MBSC.WS) in Q2 2023, closing a stake of 13,100 shares — an estimated $4.72K sold.
Prelude Capital Management first reported a position in MBSC.WS in Q1 2023 and held it in 1 quarter. The position peaked at $4.72K in Q1 2023. 38 funds tracked by Wall St. Rank hold MBSC.WS as of Q2 2023.
- Prelude Capital Management reported no remaining M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q2 2023 after selling out during the quarter.
- Prelude Capital Management sold 13,100 M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q2 2023, an estimated $4.72K.
- Prelude Capital Management first reported a position in M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q1 2023 and held it in 1 quarter.
- Prelude Capital Management's M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $4.72K in Q1 2023.
- 38 funds tracked by Wall St. Rank held M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q2 2023.
Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.